Difference between revisions of "Team:Virginia/Collaborations"

Line 8: Line 8:
 
<div style = 'padding-right: 90px; padding-left: 90px; line-height: 25px;' >
 
<div style = 'padding-right: 90px; padding-left: 90px; line-height: 25px;' >
 
<h3>Delaware</h3>
 
<h3>Delaware</h3>
<p>Since the Mid-Atlantic iGEM Meet-Up, we have been working with University of Delaware to help them establish a foundation for their new team.  By establishing this mentorship, we have been helping them by offering them a diverse set of protocols, templates/methods for brainstorming and designing iGEM Projects, and multiple calls discussing qualities of a successful iGEM project.</p>
+
<p>Since the Mid-Atlantic iGEM Meet-Up, we have been working with University of Delaware to help them establish a foundation for their new team.  By establishing this mentorship, we have been helping them by offering them a diverse set of protocols, providing templates/methods for brainstorming and designing iGEM Projects, and have been available for calls discussing qualities of a successful iGEM project.</p>
 
<h3>Manchester</h3>
 
<h3>Manchester</h3>
<p>We helped contribute to Manchester’s Collaboration which focused on synthesizing and making a comprehensive analysis, comparing how different countries and regions around the world make policy decisions regarding Synthetic Biology. A link to this collaboration can be found <a href = "https://2017.igem.org/Team:Manchester/Collaborations">here.</a></p>
+
<p>Involvement with Manchester began when they expressed interest in a business model for their device. Our conversations led us to find that there are major differences with regard to GMM laws across the world. Together, we helped synthesize questions that revealed these inconsistencies among nations. Additionally, we researched and submitted summaries detailing United States law with respect to GMMs within the confines of the targeted questions. Our major collaboration, outside of contributing US law, was in developing a cohesive way for demonstrating the differences between countries. A link to this collaboration can be found <a href = "https://2017.igem.org/Team:Manchester/Collaborations">here.</a></p>
 
<h3>William and Mary</h3>
 
<h3>William and Mary</h3>
<p>After our Mid-Atlantic Meet-Up, William and Mary offered us a set of protocols which helped us troubleshoot our team’s issues working with some of the more standard promoter work. </p>
+
<p>After our Mid-Atlantic Meet-Up, William and Mary offered us a set of protocols related to Arabinose-inducible promoters, which helped us further characterize the promoters in <i>Paracoccus denitrificans</i> and use the pBAD promoter in our final tested device. </p>
 
</div>
 
</div>
  
 
</html>
 
</html>

Revision as of 00:22, 1 November 2017




Collaborations



Delaware

Since the Mid-Atlantic iGEM Meet-Up, we have been working with University of Delaware to help them establish a foundation for their new team. By establishing this mentorship, we have been helping them by offering them a diverse set of protocols, providing templates/methods for brainstorming and designing iGEM Projects, and have been available for calls discussing qualities of a successful iGEM project.

Manchester

Involvement with Manchester began when they expressed interest in a business model for their device. Our conversations led us to find that there are major differences with regard to GMM laws across the world. Together, we helped synthesize questions that revealed these inconsistencies among nations. Additionally, we researched and submitted summaries detailing United States law with respect to GMMs within the confines of the targeted questions. Our major collaboration, outside of contributing US law, was in developing a cohesive way for demonstrating the differences between countries. A link to this collaboration can be found here.

William and Mary

After our Mid-Atlantic Meet-Up, William and Mary offered us a set of protocols related to Arabinose-inducible promoters, which helped us further characterize the promoters in Paracoccus denitrificans and use the pBAD promoter in our final tested device.